This time, in a glitzy production featuring Mark Strong and Lesley Manville as the star-crossed lovers, the blood-red digits count down to the results of an election, which Strong’s Oedipus ...

In the face of this, women are all over the world are leading movements for peace and to rebuild communities, and there is strong evidence suggesting that women’s participation in peace processes ...

The battlelines are revealed by OCTA Research, which reports as of September (all figures in percent) the following: “Pro-Marcos,” 38; “Pro-Duterte,” 15; and “Pro-Opposition” 7 (apparently meaning the ...

Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch In a strong field of powerhouse SGLT2 inhibitors, including Boehringer Ingelheim and Eli ...

Lexicon CEO and director Dr Mike Exton stated: “We are pleased to be working with Viatris, a company with strong cardiometabolic expertise, global commercial capabilities and a successful track record ...

Jeremy Strong attends 'The Apprentice" NY premiere at the DGA theatre in New York, October 8, 2024 CREDIT: Angela Weiss / AFP via Getty Images Jeremy Strong has admitted that working on Succession ...

Actor Jeremy Strong, best known for playing troubled media heir Kendall Roy in TV’s Succession, has told NME that he’s definitely on the cast for upcoming Bruce Springsteen biopic Deliver Me ...

According to Bynfezia’s label, octreotide works by mimicking the effects of the natural hormone somatostatin, exerting a strong inhibitory effect on ... After Previous Rejection, Lexicon’s Insulin ...

The deal is a boost to Lexicon, because the company was unlikely to try to sell Inpefa outside of the U.S. on its own, according to Jefferies’ Tsai. Meanwhile, the drug fits into plans by Viatris to ...

Actor Jeremy Strong has said Donald Trump calling those involved with his new film The Apprentice "human scum" is "all the more reason" cinemagoers should go and see it. Ahead of the UK release of ...

THE WOODLANDS, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals ... a company with strong cardiometabolic expertise, global commercial capabilities and a successful track record ...

Viatris is ponying up $25 million upfront to obtain the rights to sell Lexicon Pharmaceuticals ... Inpefa is part of a strong class of SGLT2 inhibitors that also includes Boehringer Ingelheim ...